New single-dose antibiotic may help battle superbug MRSA

June 5, 2014 9:06 AM

581 0

A single dose of a newly developed antibiotic may be just as effective as a longer course of standard antibiotics for the treatment of serious skin infections, including drug-resistant MRSA, which can be deadly.

The single dose of the new drug, called oritavancin, was found to cure MRSA, or methicillin-resistant Staphylococcus aureus, which typically requires a patient take antibiotics for up to 10 days and may involve a hospital stay.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page